Ekso BionicsEKSO
About: Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.
Employees: 72
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
100% more call options, than puts
Call options by funds: $12K | Put options by funds: $6K
2.34% more ownership
Funds ownership: 8.57% [Q1] → 10.91% (+2.34%) [Q2]
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
0% less capital invested
Capital invested by funds: $2.09M [Q1] → $2.08M (-$4.22K) [Q2]
20% less funds holding
Funds holding: 35 [Q1] → 28 (-7) [Q2]
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
HC Wainwright & Co. Swayampakula Ramakanth 26% 1-year accuracy 35 / 136 met price target | 871%upside $10 | Buy Reiterated | 30 Jul 2024 |